Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,579 followers.

RT @sejadiMD: My argument in 2007 & 2015 for low dose rapamycin + ipilimumab in organ transplant. Kudos RC and brave clinicians https://t.c…

My argument in 2007 & 2015 for low dose rapamycin + ipilimumab in organ transplant. Kudos RC and brave clinicians https://t.co/TwvkUJPn9w

AMAZING...gave anti-ctla4 ipilimumab to a liver transplant patient who got melanoma and the liver was not rejected http://t.co/bO5bEZ1FaC

AMAZING...gave anti-ctla4 ipilimumab to a liver transplant patient who got melanoma and the liver was not rejected http://t.co/bO5bEZ1FaC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.